Seeing Is Believing

Currently out of the existing stock ratings of Dan Leonard, 262 are a BUY (64.06%), 127 are a HOLD (31.05%), 20 are a SELL (4.89%).
Analyst Dan Leonard, currently employed at RBC, carries an average stock price target met ratio of 67.76% that have a potential upside of 17.45% achieved within 270 days. Previously, Dan Leonard worked at WELLS FARGO, UBS.
Dan Leonard’s has documented 829 price targets and ratings displayed on 48 stocks. The coverage is on Healthcare, Basic Materials, Industrials sectors.
Most recent stock forecast was given on TMO, Thermo Fisher Scientific.
Analyst best performing recommendations are on STVN (STEVANATO GROUP SPA).
The best stock recommendation documented was for CRL (CHARLES RIVER LABORATORIES) at 2/25/2026. The price target of $175 was fulfilled within 1 day with a profit of $7.44 (4.44%) receiving and performance score of 44.4.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 26-Feb-2026
$195
$21.93 (12.67%)
$150
19 days ago
(07-Oct-2026)
21/22 (95.45%)
$25.91 (15.32%)
140
Buy Since 25-Nov-2025
$185
$11.93 (6.89%)
$155
1 months 29 days ago
(27-Aug-2026)
28/31 (90.32%)
$27.31 (17.32%)
400
Buy Since 27-Feb-2026
$175
$1.93 (1.12%)
$150
1 months 29 days ago
(27-Aug-2026)
2/2 (100%)
$17.31 (10.98%)
103
Buy Since 02-Jun-2026
$180
$6.93 (4.00%)
$155
1 months 29 days ago
(27-Aug-2026)
4/5 (80%)
$22.31 (14.15%)
109
Buy Since 09-Oct-2025
$190
$16.93 (9.78%)
$180
1 months 29 days ago
(27-Aug-2026)
1/3 (33.33%)
$32.31 (20.49%)
348
Which stock is Dan Leonard most bullish on?
Which stock is Dan Leonard most reserved on?
What Year was the first public recommendation made by Dan Leonard?